Clinical trial
Radiolabeled Monoclonal Antibody in Treating Patients With Advanced Ovarian…
NCT00072410 · Ludwig Institute for Cancer Research, Other · Completed
Key facts
| NCT number | NCT00072410 |
|---|---|
| Title | Radiolabeled Monoclonal Antibody in Treating Patients With Advanced Ovarian Epithelial Cancer |
| Official title | Single-Dose, Cohort Study of Increasing Doses of Yttrium-90 Conjugated to Humanized Monoclonal Antibody 3S193 (90Y-hu3S193) in Patients With Advanced Ovarian Cancer |
| Lead sponsor | Ludwig Institute for Cancer Research, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Ovarian Cancer |
| Intervention type | Biological |
| Interventions | 90Y-hu3S193, 111In-hu3S193 |
| Enrollment | 7 |
| Start date | Nov 1, 2003 |
| Primary completion | May 1, 2005 |
| Completion | Nov 15, 2006 |
| First posted | Nov 6, 2003 |
| Last update posted | Oct 4, 2023 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: